Skip to main content

Table 2 Multivariate analysis of overall survival and progression-free survival in relation to clinical-pathologic characteristics

From: Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy

Characteristics

PFS

OS

HR (95 % CI)

P value

HR (95 % CI)

P value

Gender (Female vs Male)

1.936 (1.044–3.590)

0.036

2.039 (1.178–3.531)

0.011

Age (≥65 vs <65)

0.381 (0.175–0.831)

0.015

0.481 (0.236–0.980)

0.044

Clinical T stage (T3-4 vs T2)

0.928 (0.507–1.697)

0.808

1.010 (0.575–1.776)

0.972

Clinical TNM stage (III vs II)

0.697 (0.389–1.249)

0.226

0.692 (0.404–1.185)

0.180

ypN stage (N1vs N0)

0.427 (0.248–0.734)

0.002

0.406 (0.240–0.686)

0.001

  1. Note: HR: hazard ratio, CI: confidence interval, ypN: post-therapy pathologic lymph node status; pCR: pathologic complete response; ypT0N1: pathologic complete response in tumor but residual lymph node metastasis after neoadjuvant radiotherapy and surgery
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us